ARTICLE | Clinical News
Clearazide mechlorethamine: Phase II data
October 11, 2010 7:00 AM UTC
Yaupon Therapeutics Inc., Radnor, Pa. Product: Clearazide mechlorethamine Business: Cancer Molecular target: NA Description: Topical form of nitrogen mustard, an alkylating agent Indication: Treat cu...